English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Apr 16, 2026

Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’

Patient Daily | Apr 10, 2026

Heartland Institute's Milloy on vaccine liability: 'Simply ending immunity on vaccines will only make things worse'

Patient Daily | Apr 10, 2026

Cornell Health Policy Center survey: 78% of experts say weakening vaccine liability protections would curb innovation

Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'

Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'

A. D. Brady | Mar 30, 2026

Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’

Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'

Patient Daily | Mar 30, 2026

Biotechnology Innovation Organization survey finds strong voter support for PBM reforms

Trending

+ Pharmaceuticals
Patient Daily | May 26, 2026

ASCO 2026 to spotlight Revolution Medicines and bispecific antibody advances

+ Regulatory
Patient Daily | May 26, 2026

Senate candidate Dr. El-Sayed on PBMs: ‘They just extract profit from patients’

+ Regulatory
A. J. Alarcon | May 26, 2026

Ellen Lubensky discusses mental health reform and informed consent on Health Policy Podcast

+ Regulatory
Patient Daily | May 25, 2026

National Alliance of Healthcare Purchaser Coalitions chief of staff on 340B: ‘340B needs a big dose of transparency’

  • « First
  • «
  • 1
  • 2
  • 3
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily